Changes in catecholamine plasma levels after application of sumatriptan succinate or ergotamine tartrate in migraine patient during the attack and the pain-free interval
T. Lorentz et al., Changes in catecholamine plasma levels after application of sumatriptan succinate or ergotamine tartrate in migraine patient during the attack and the pain-free interval, NERVENHEILK, 18(5), 1999, pp. 264-266
The effects of ergotamine and sumatriptan upon the concentrations of catech
olamines (epinephrine, norepinephrine, dopamine) in venous blood plasma wer
e investigated in a group of migraine patients. The catecholamine concentra
tions were measured between and during attacks by the HPLC method. Ergotami
ne tartrate has been administered by a spray with a dosage of 0.5 mg. Sumat
riptan succinate was given subcutaneously with a dosage of 6 mg. We found t
hat the concentration of norepinephrine in the venous blood plasma decrease
d significantly (p <0,001; 2-tails sign test) during the migraine attack on
ly after the administration of sumatriptan. All other parameters were not i
nfluenced by the two substances. Moreover we found a highly significant cli
nical efficacy of both, sumatriptan and ergotamine, the former significantl
y faster than ergotamine.